Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q2 2023 Earnings Call Transcript July 27, 2023
Vanda Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is $0.05 EPS, expectations were $0.13.
Operator: Good afternoon. My name is Audra, and I will be your conference operator today. At this time, I would like to welcome everyone to the Q2 2023 Vanda Pharmaceuticals Inc. Earnings Call. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks there...
